Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Journal of Medicinal Chemistry
|
May 10, 1996
Asymmetric syntheses, opioid receptor affinities, and antinociceptive effects of 8-amino-5,9-methanobenzocyclooctenes, a new class of structural analogues of the morphine alkaloids
A G Schultz, A Wang, C Alva, et al.
Behavioural Pharmacology
|
November 1, 2002
Delta opioid antagonist effects of buprenorphine in rhesus monkeys
S S Negus, J M Bidlack, N K Mello, et al.
Peptide Research
|
May 1, 1995
Six highly active mu-selective opioid peptides identified from two synthetic combinatorial libraries
C T Dooley, R A Kaplan, N N Chung, et al.
Biochemical Pharmacology
|
April 13, 2001
Kappa-opioid receptor agonist suppression of HIV-1 expression in CD4+ lymphocytes
P K Peterson, G Gekker, J R Lokensgard, et al.
Journal of Medicinal Chemistry
|
January 14, 2000
Synthesis and opioid receptor affinity of morphinan and benzomorphan derivatives: mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine dependence
J L Neumeyer, J M Bidlack, R Zong, et al.
Science (New York, N.Y.)
|
December 23, 1994
An all D-amino acid opioid peptide with central analgesic activity from a combinatorial library
C T Dooley, N N Chung, B C Wilkes, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 15, 2000
8-Aminocyclazocine analogues: synthesis and structure-activity relationships
M P Wentland, G Xu, C L Cioffi, et al.
NIDA Research Monograph
|
January 1, 1996
Molecular and biochemical evidence for receptors for drugs of abuse on immune cells
L Y Liu-Chen, J M Bidlack, T J Rogers, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 23, 1996
kappa opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression
C C Chao, G Gekker, S Hu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 1999
Genetic alteration of phospholipase C beta3 expression modulates behavioral and cellular responses to mu opioids
W Xie, G M Samoriski, J P McLaughlin, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Journal of Medicinal Chemistry
|
May 10, 1996
Asymmetric syntheses, opioid receptor affinities, and antinociceptive effects of 8-amino-5,9-methanobenzocyclooctenes, a new class of structural analogues of the morphine alkaloids
A G Schultz, A Wang, C Alva, et al.
Behavioural Pharmacology
|
November 1, 2002
Delta opioid antagonist effects of buprenorphine in rhesus monkeys
S S Negus, J M Bidlack, N K Mello, et al.
Peptide Research
|
May 1, 1995
Six highly active mu-selective opioid peptides identified from two synthetic combinatorial libraries
C T Dooley, R A Kaplan, N N Chung, et al.
Biochemical Pharmacology
|
April 13, 2001
Kappa-opioid receptor agonist suppression of HIV-1 expression in CD4+ lymphocytes
P K Peterson, G Gekker, J R Lokensgard, et al.
Journal of Medicinal Chemistry
|
January 14, 2000
Synthesis and opioid receptor affinity of morphinan and benzomorphan derivatives: mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine dependence
J L Neumeyer, J M Bidlack, R Zong, et al.
Science (New York, N.Y.)
|
December 23, 1994
An all D-amino acid opioid peptide with central analgesic activity from a combinatorial library
C T Dooley, N N Chung, B C Wilkes, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 15, 2000
8-Aminocyclazocine analogues: synthesis and structure-activity relationships
M P Wentland, G Xu, C L Cioffi, et al.
NIDA Research Monograph
|
January 1, 1996
Molecular and biochemical evidence for receptors for drugs of abuse on immune cells
L Y Liu-Chen, J M Bidlack, T J Rogers, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 23, 1996
kappa opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression
C C Chao, G Gekker, S Hu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 1999
Genetic alteration of phospholipase C beta3 expression modulates behavioral and cellular responses to mu opioids
W Xie, G M Samoriski, J P McLaughlin, et al.
Page
of 10